INS and type 1 diabetes mellitus: Measures of C-peptide alone provide an incomplete portrait of beta cell function and disease progression during the early stages of type 1 diabetes, as they do not account for changing insulin sensitivity and the non-linear fluctuations in insulin secretion described in stage 1 and stage 2 type 1 diabetes.